The job KW has done is truly remarkable, to take nothing away from everyone else involved who are furthering this technology. Not only has KW brought this patented platform technology to relevance on multiple levels, but he has also culminated an Intl' Diabetes Consortium soon to cure diabetes. Furthermore, he has secured a robust IP portfolio going forward. Getting into the Phase 2b is crucial and securing FDA Breakthrough Therapy will thrust PMCB into the limelight. Stay long. Go PMCB!